Evidence map›Paper›PMID 25182303›Full record

ArticleDrug delivery2016

A method to improve the efficacy of topical eflornithine hydrochloride cream.

Amit Kumar, Youssef W Naguib, Yan-Chun Shi, Zhengrong Cui

Abstract read
In one paragraph

Article in Drug delivery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. In Vivo Efficacy of Curcumin and Curcumin Nanoparticle inPathogens (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amit Kumara Pharmaceutics Division , College of Pharmacy, The University of Texas at Austin , Austin , TX , USA and.
Youssef W Naguiba Pharmaceutics Division , College of Pharmacy, The University of Texas at Austin , Austin , TX , USA and.
Yan-Chun Shib Research Center of Molecular Biology, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot , Inner Mongolia , China.
Zhengrong Cuia Pharmaceutics Division , College of Pharmacy, The University of Texas at Austin , Austin , TX , USA and.
The University of Texas at Austin · US

Funding

Topical DNA immunization by modifying the hair follicle cycleR01AI078304 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI CUI, ZHENGRONG · 2008 to 2011
$1.4M
NIAID NIH HHS R01 AI078304
6 · The paper itself

Abstract

contextFacial hirsutism is a cosmetic concern for women and can lead to significant anxiety and lack of self-esteem. Eflornithine cream is indicated for the treatment of facial hirsutism. However, limited success rate and overall patient's satisfaction, even with a long-term and high-frequency application, leave room for improvement.

objectiveThe objective of this study is to test the effect of microneedle treatment on the in vitro skin permeation and the in vivo efficacy of eflornithine cream in a mouse model. MATERIALS AND

methodIn vitro permeation study of eflornithine was performed using Franz diffusion cell. In vivo efficacy study was performed in a mouse model by monitoring the re-growth of hair in the lower dorsal skin of mice after the eflornithine cream was applied onto an area pretreated with microneedles. The skin and the hair follicles in the treated area were also examined histologically. RESULTS AND DISCUSSION: The hair growth inhibitory activity of eflornithine was significantly enhanced when the eflornithine cream was applied onto a mouse skin area pretreated with microneedles, most likely because the micropores created by microneedles allowed the permeation of eflornithine into the skin, as confirmed in an in vitro permeation study. Immunohistochemistry data revealed that cell proliferation in the skin and hair follicles was also significantly inhibited when the eflornithine cream was applied onto a skin area pretreated with microneedles.

conclusionThe integration of microneedle treatment into topical eflornithine therapy represents a potentially viable approach to increase eflornithine's ability to inhibit hair growth.

Indexed as

Administration, TopicalAdministration, CutaneousAnimalsEflornithineFaceFemaleHair FollicleHirsutismHumansMiceSkinEflornithineCell proliferationhair growth inhibitionmicroneedlesskin permeationunwanted hair growth

Identifiers

PMID25182303
PMCPMC4348346
OpenAlexW1974434472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.